Roxadustat advances as a promising oral treatment for anemia in lower-risk myelodysplastic syndromes, targeting high ...

FibroGen has reached agreement with the FDA on important design elements for a pivotal Phase 3 clinical trial for roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic ...

Investing.com -- FibroGen Inc (NASDAQ: FGEN) stock jumped 9.9% following positive feedback from the U.S. Food and Drug Administration supporting the advancement of roxadustat for treating anemia in ...

According to KEM doctors, the patient received one unit of ‘O’ Positive whole blood from Shatabdi BDBA Hospital, Kandivali. But, the case has exposed how poorly equipped civic- and state-run hospitals ...

Technological advances and new tools may offer the best chance to help underdeveloped blood deserts in the short term.

Overview of Artificial Blood Cells MarketThe global Artificial Blood Cells Market is valued at USD 1.355 Billion in 2024 and is projected to reach a value of USD 5.265 Billion by 2035 at a CAGR ...

Bristol Myers Squibb & Co. (NYSE:BMY) on Friday announced topline results from the Phase 3 INDEPENDENCE trial evaluating Reblozyl (luspatercept-aamt) with concomitant janus kinase inhibitor (JAKi ...

Total knee arthroplasty is a commonly performed procedure with postoperative complications including blood loss, pain, and ...

The post mortem reports of three lion cubs who died in Gujarat’s Amreli district recently have cited anemia and pneumonia as the causes, a senior forest department official said on Friday. Two of the ...

Download Free Sample of This Strategic Report with Industry Analysis @ The Saudi Arabia Blood Banking Market holds significant importance within the healthcare landscape of the country. Blood banking ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

A Harper County horse has been confirmed with West Nile Virus, according to the KDA Division of Animal Health.